Glaucoma as a neurodegenerative disease
A 55% reduction of muscle glycogen consumption at 50% VO2 max and a 38% reduction at 80% VO2 max
ClinicalTrials.gov identifier: NCT02166242
And if regulators focus only on whether peptides fit neatly into traditional drug categories, they may miss the bigger public health problem entirely
Abstract Background Insulin-like growth factor (IGF)-1 and its binding proteins are important in cancer growth, especially in prostate cancer
Chinese manufacturers (WuXi TIDES, GL Biochem, Hybio) are the primary drivers of volume growth at lower ASPs, while Western manufacturers (Bachem, CordenPharma) are defending margins through quality premium, regulatory compliance, and complex molecule specialisation